Observational studyHealth and quality of life outcomes2020

Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States.

Himani Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.